INVESTIGACIÓN TRASLACIONAL EN EL PACIENTE CRÍTICO
CRITLAB
Mutua de Terrassa
Terrassa, EspañaPublicaciones en colaboración con investigadores/as de Mutua de Terrassa (12)
2024
-
Clustering COVID-19 ARDS patients through the first days of ICU admission. An analysis of the CIBERESUCICOVID Cohort
Critical Care, Vol. 28, Núm. 1
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis
The European respiratory journal, Vol. 61, Núm. 3
-
Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients
Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215
2022
-
A first update on mapping the human genetic architecture of COVID-19
Nature
-
Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study
Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864
-
Methodology of a Large Multicenter Observational Study of Patients with COVID-19 in Spanish Intensive Care Units
Archivos de Bronconeumologia, Vol. 58, pp. 22-31
-
Whole-genome sequencing reveals host factors underlying critical COVID-19
Nature, Vol. 607, Núm. 7917, pp. 97-103
2021
-
Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)
Critical Care
-
The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients
Critical Care, Vol. 25, Núm. 1
2018
-
Prevention and treatment of tuberculosis infection in candidates for biologic therapy: A multidisciplinary consensus statement adapted to the dermatology patient
Actas Dermo-Sifiliograficas, Vol. 109, Núm. 7, pp. 584-601
2016
-
Consensus Document on Prevention and Treatment of Tuberculosis in Patients for Biological Treatment
Archivos de Bronconeumologia, Vol. 52, Núm. 1, pp. 36-45